An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation

British Journal of Cancer

Volumn 86, Issue 5, 2002, Pages 744-749

  Cascinu, S ^a   Graziano, F ^b   Catalano, V ^c   Staccioli, M P ^c   Rossi, M C ^c   Baldelli, A M ^c   Barni, S ^d   Brenna, A ^e   Secondino, S ^d   Muretto, P ^c   Catalano, G ^c  

^a ACADEMIC HOSPITAL OF PARMA   (Italy)

^b Hospital of Urbino   (Italy)

^c SAN SALVATORE HOSPITAL   (Italy)

^d Hospital of Treviglio   (Italy)

^e Department of Pediatrics   (Italy)

Author keywords

Angiogenesis; Apoptosis; BAX; Chemotherapy; Metastasis; P53; Radiotherapy; Rectal cancer; Vascular endothelial growth factor

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN BAX; PROTEIN P53; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; GENE OVEREXPRESSION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECTUM CANCER; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 18344388638     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600155     Document Type: Article

References (43)

1. p53 status: An indicator for the effect of preoperative radiotherapy of rectal cancer
2. Implication of vascular endothelial growth factor in the development and metastasis of human cancers
3. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
4. Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer
5. Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer. Relationships with tumour recurrence and resistance to adjuvant chemotherapy
6. Association of p53 accumulation with TP53 mutations, loss of heterozygosity at 17p13, and DNA ploidy status in 273 colorectal carcinomas
7. Regression models and life-tables
8. Apoptosis and expression of BAX, Bcl-x and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas and association with the p53 genotype/phenotype
9. P53 alterations have no prognostic or predictive significance in Dukes'C rectal cancer
10. Tumour angiogenesis and tissue factors
11. Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients
12. Tumour-derived expression of vascular endothelial growth factor is a critical factor in tumour expansion and vascular function
13. Bax and Bcl-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical cancer
14. p53 mutations in human cancers
15. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer
16. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumour vascularity and liver metastasis
17. Transient increase of apoptosis and BAX expression occurring during radiotherapy in patients with invasive cervical carcinoma
18. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients
19. Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes'B2 rectal cancer after curative resection
20. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma
21. Tumour markers of prognosis in colorectal cancer
22. Tumour suppressor p53 is a direct transcriptional activator of human BAX gene
23. Adjuvant therapy of rectal cancer
24. Prognostic value of positive lymph nodes in rectal cancer
25. Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma
26. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and BAK expressions in colorectal carcinomas
27. Bax protein expression correlates with radiation-induced apoptosis in radiation therapy for cervical carcinoma
28. Dysregulation of apoptosis in cancer
29. The molecular and cellular basis of radiosensitivity: Implications for understanding how normal tissues and tumours respond to therapeutic radiation
30. Evaluation of p53, Ki-67 and DNA ploidy in both primary rectal carcinomas and locally recurrent tumours
31. p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer
32. Apoptosis in rectal cancer: Prognostic significance in comparison with clinical histopathologic, and immunohistochemical variables
33. Reciprocal relationship between the tumour suppressors genes p53 and BAX in primary colorectal cancers
34. p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer
35. Impact of surgical and pathologic variables in rectal cancer: A United States Community and Cooperative Group Report
36. Analysis of the p53/BAX pathway in colorectal cancer: Low BAX is a negative prognostic factor in patients with resected liver metastases
37. Enhanced induction of apoptosis of human gastric carcinoma cells after preoperative treatment with 5-fluorouracil
38. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer
39. Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer
40. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer
41. Adjuvant therapy for colorectal cancer: Past accomplishments, future directions
42. Induction of BAX by genotoxic stress in human cells correlates with normal p53 status and apoptosis
43. BAX suppresses tumourigenesis and stimulates apoptosis in vivo